Stock Events

Stock Events

Quantum Genomics

€0

0

-€0.07-100% Today

Statistics

Day High

-

Day Low

-

52W High

-

52W Low

-

Volume

-

Avg. Volume

-

Mkt Cap

0

P/E Ratio

-

Dividend Yield

-

Dividend

-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 2QG.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Novartis is a global healthcare company that operates in the pharmaceuticals sector, directly competing with Quantum Genomics in the development of cardiovascular drugs.

Pfizer is a large pharmaceutical company with a broad product portfolio, including treatments for cardiovascular diseases, making it a competitor to Quantum Genomics.

Merck & Co., Inc. is involved in the discovery, development, manufacturing, and marketing of pharmaceuticals, including those for cardiovascular health, competing with Quantum Genomics.

AstraZeneca operates in the biopharmaceutical sector, focusing on the development of drugs for various diseases, including cardiovascular, which competes with Quantum Genomics' focus.

Amgen is a biopharmaceutical company that develops and manufactures innovative human therapeutics, including cardiovascular drugs, competing with Quantum Genomics.

Bristol-Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company with a focus on discovering, developing, and delivering innovative medicines, including for cardiovascular diseases, making it a competitor to Quantum Genomics.

Johnson & Johnson

Johnson & Johnson operates in the pharmaceutical sector with a wide range of products, including cardiovascular drugs, directly competing with Quantum Genomics.

GlaxoSmithKline is a healthcare company that researches and develops a wide range of medicines, including those for cardiovascular diseases, competing with Quantum Genomics.

Sanofi is a global healthcare leader that discovers, develops, and distributes therapeutic solutions, including for cardiovascular diseases, making it a competitor to Quantum Genomics.

AbbVie is a biopharmaceutical company that has a range of products for various therapeutic areas, including cardiovascular diseases, competing with Quantum Genomics.

About

Quantum Genomics Société Anonyme, a biopharmaceutical company, develops drugs to treat cardiovascular diseases. It develops drugs based on brain aminopeptidase A inhibition (BAPAI) platform primarily to treat high blood pressure and heart failure. The company develops firibastat, a monotherapy drug that is in pivotal Phase III study for the treatment of hypertension, as well as in clinical trial for the treatment of heart failure. It is also developing QGC011 to treat hypertension with combination therapy; and QGC006 and QGC606 drug for the treatment of hypertension and heart failure. The company was incorporated in 2005 and is based in Paris, France.

Show more...

CEO

Mr. Mathieu Bigois

Employees

3

Country

France

ISIN

FR0011648971

Listings

0 Comments

Share your thoughts

FAQ

What is Quantum Genomics stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Quantum Genomics stocks are traded under the ticker 2QG.STU.

Is Quantum Genomics stock price growing?▼

2QG.STU stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Quantum Genomics has showed a +0% increase.

How many employees does Quantum Genomics have?▼

As of April 11, 2026, the company has 3 employees.

In which sector is Quantum Genomics located?▼

Quantum Genomics operates in the Health & Wellness sector.

When did Quantum Genomics complete a stock split?▼

Quantum Genomics has not had any recent stock splits.

Where is Quantum Genomics headquartered?▼

Quantum Genomics is headquartered in Paris, France.